Investing.com - Hologic reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Hologic announced earnings per share of $0.95 on revenue of $1B. Analysts polled by Investing.com anticipated EPS of $0.7121 on revenue of $904.49M.
Hologic shares are down 7% from the beginning of the year and are trading at $70.00 , down-from-52-week-high.They are outperforming the Nasdaq which is down 23.09% from the start of the year.
Hologic shares lost 1.33% in after-hours trade the report.
Hologic follows other major Healthcare sector earnings this month
Hologic's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar